Clomid (clomiphen citrate)
Clomid is the name of the company citrate’s clomiphene . Is prescribed to women to help them in ovulation. For men, administration of Clomid causes an increase in hormones that stimulate testicles. As a result, natural testosterone production increases, too. This effect is generally beneficial for athletes in particular to an end, when endogenous testosterone level is below normal. When athletes interrupt useing steroids, testosterone secretion is breaking up. If endogenous testosterone levels did not return to normal, may have a considerable loss in size and strength. Clomid plays a role in preventing such a drop in performance athletes. Bodybuilders found that a daily dose of 50-100mg of clomifen citrate taken for 2 weeks, they bring endogenous testosterone secretion at an acceptable level. Clomid will gradually raise testosterone levels during what is given. Since an increase of testosterone is often desirable, athletes often use hCG for 2 weeks there and then continue treatment with Clomid. It is also effective and antiestrogen. Most of the athletes have an increased level of estrogen at the end of a cycle of steroids. A high estrogen level combined with low testosterone secretion, athletes subject to a serious risk to ginecomastic. With the administration of Clomid, athletes benefit from the double to be blocked conversion of anabolic substances used in estrogen-while increasing endogenous testosterone secretion. Regarding the toxicity and side effects, clomid is considered to be a safe drug. The bodybuilders rarely have problems, but possible side effects can affect view: flame red or to temporarily blur, obscure. Citrate clomifen is available on the black market. Until recently, it could relatively easily obtain ordered him from outside. Current price is between $ 2-4 / 50mg tablet. Names such as Clomiphene citrate in Greece Anfarm to meet frequently on the black market and buy at the price of 1 $ / tablet.
Tags: clomid, Clomiphene citrate, estrogen, testosterone secretion
Steroids | Lucian Modreanu | 
May 12, 2009 10:14 AM
Subscribe